Guidant Carotid Stent Study Will Enroll 400 High-Risk Patients Into Single Arm

Guidant's Acculink for Revascularization of Carotids in High-Risk Patients (ARCHeR) trial, announced May 16, may represent a quicker but more restricted road to approval for the company's carotid artery stent.